Arvan Company - A pioneer in pharmaceutical excellence in Iran

"Providing innovative and high-quality healthcare solutions through strategic partnerships since 2008."

Our services

Distribution network

Efficient nationwide network for delivery to pharmacies, hospitals and clinics

Regulatory affairs

IFDA expert guidance and international regulations, including US FDA standards for partnerships

Strategic partnerships

Collaborating with global and local companies to introduce innovative medicines

Marketing

Developing appropriate strategies for advertising pharmaceutical products in Iran, ensuring market compliance and differentiation

Company History

Arvan is a key player in the Iranian pharmaceutical sector, focusing on oncology, neurology, dermatology and rare diseases.

Long-standing relationships with healthcare professionals and medical communities.

Emphasis on the support of PMA Investment Holding, including its five subsidiaries (Ziist Daru, Papyrus, Plastic Machine, Paxator Varna and Pad Alvan).

Company Overview

Mission: "To provide high-quality pharmaceutical products to the Iranian market through strategic partnerships and specialized marketing, ensuring accessibility and affordability."

Vision: "To become a leading pharmaceutical marketing and distribution company in Iran, recognized for excellence, innovation, and compliance with global standards."

Foundation: Established in 2008, under the supervision of PMA Investment Holding.

Coherence at a glance
GDP implemented project
0
Average years of participation
0
Relationships of innovators
0
Experience in CDMO
0
Compliance with FDA standards
0
Successful collaborations
0
EDQM accredited sites
0
Production sites
0
Research and development centers
0
Broadcasting and distribution agency
0
Goals and achievements
Overview of the Arvan Company Team
  1. Our team brings over 20 years of collective experience in pharmaceuticals, specializing in sales, marketing, regulatory compliance and team management.
  2. Sales & Marketing: Proven success in delivering specialty and consumer health products.
  3. Regulatory Compliance: In-depth knowledge of IFDA and international guidelines.
  4. Human Resource Management: Utilizing cutting-edge methodologies such as Situational Leadership II, Enneagram and HBDI.
  5. Training & Development: Comprehensive programs aligned with global best practices.
Arvan Company's Key Expertise
  • Sales and Marketing: Proven success in delivering specialty and consumer health products.
  • Regulatory Compliance: In-depth knowledge of IFDA and international guidelines.
  • Human Resource Management: Utilizing advanced methodologies such as Situational Leadership II, Enneagram, and HBDI.
  • Training and Development: Comprehensive programs aligned with global best practices.
Remarkable achievements
  • Successful partnerships with multinational giants.
    Expertise in managing complex and high-risk projects.
  • Compliance with US Food and Drug Administration (FDA) and Good Distribution Practices (GDP) standards.
  • Deep knowledge of the Iranian market to address unmet medical needs.
Partnerships in collaboration and distribution networks
  • US and Western Countries Partnership Focus
  • Arvan is actively seeking marketing licenses from US pharmaceutical companies to distribute innovative products in Iran.
Presence in the market
  • 17 years of combined experience through PMA’s manufacturing arm and Arvan’s marketing since 2008.
  • Diverse portfolio in oncology, neurology and specialty drugs.
  • Nationwide distribution network covering retail pharmacies, hospitals and clinics.
  • Positioned to capture a growing share of the Iranian pharmaceutical market.
  • Supported by PMA’s vertically integrated supply chain for cost efficiency and quality.
Arwan's vision
  • Expanding U.S. partnerships in oncology, biologics, and chronic disease treatment.
  • Diversifying into advanced therapies and biosimilars.
  • Investing in digital marketing and data analytics to increase market penetration.
Latest news